lip care bath body base

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Cosmetic washes, gels, and emulsions use glycerin in a polyol-humectant role; the listed level is for formulation development.

3. Typical use levels (formulation guide)

• The level shown for gels and serums is 3–8% as a formulation guide.
• Creams: 2–5% in this reference.
• For rinse-off, use 2–4% as a formulation guide.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• A CosIng entry naming Glycerin does not by itself approve the purchased grade or complete cosmetic.
• Before EU placement, Regulation (EC) No 1223/2009 requires the final cosmetic with Glycerin to undergo a safety assessment for the specific product as it will be marketed.
• Review the supplier TDS for the received Glycerin grade, together with the target market's current filing requirements.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; it makes no claim of drug or OTC authorization so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; choose a package with oxidation sensitivity in view; confirm final stability and pack compatibility on a representative batch.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Glycerin highlights humectant function.

• The listed information does not support claims of drug action or cure, or a product certification outside the supporting records.
• This guide to Glycerin should not be cited in support of a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• Gel-creams: 2–6% for the formula.
• The stated reference for dry oils is 10–30% in this reference.
• The level shown for balms is 5–15% as a formulation guide.

The oil phase is the addition point for Squalane, with no high-shear wax operation.

4. Regulatory sources & global compliance

• A CosIng listing for Squalane provides ingredient information, not approval of a supplied grade or finished product.
• For cosmetics placed on the EU market, Regulation (EC) No 1223/2009 requires the final cosmetic with Squalane to undergo a safety assessment for the product in its final form.
• Check the supplier's technical information for the Squalane grade and confirm the relevant market filing list.

5. Safety & risk assessment

Treat the listed amount as cosmetic-development guidance; the listed level does not itself confer drug or OTC status so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

Store the bulk in a closed container in a cool, shaded place; if oxidation risk calls for it, review a pump or airless format; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The formulation note describes Squalane as part of a cosmetic direction focused on a light-emollient role.

• The development record does not support claims of drug action or cure, or a product certification outside the supporting records.
• The cosmetic guidance for Squalane does not establish skin whitening, acne treatment, antiperspirant use, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

The reference uses shea butter for cushion in creams, balms, and hair creams. It does not assume the color or scent of an unrefined grade.

3. Typical use levels (formulation guide)

• The creams use-level reference is 2–8% as a formulation guide.
• For balms and butters, use 10–25% in this reference.

The listed method melts Butyrospermum Parkii Butter into oil and maintains shear as the blend cools to reduce graining.

4. Regulatory sources & global compliance

• A CosIng listing for Butyrospermum Parkii Butter provides ingredient information, not approval of a supplied grade or finished product.
• For cosmetics placed on the EU market, Regulation (EC) No 1223/2009 requires a safety assessment of the complete cosmetic formula containing Butyrospermum Parkii Butter before the finished product is marketed.
• Check the supplier's technical information for the Butyrospermum Parkii Butter grade and confirm the relevant market filing list.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it provides no evidence that a drug or OTC monograph applies and the final formula should undergo patch and stability assessment.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; where oxidation is a concern, evaluate airless or pump packaging; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• The cosmetic formulation concept for Butyrospermum Parkii Butter centers on shea cushion.

• The formulation note does not support drug-treatment outcomes, clinical cures, or certifications not documented for the SKU.
• The documented facts for Butyrospermum Parkii Butter does not confirm skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.